Cotización Aptevo Therapeutics - APVO

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

0.29

Postura de Compra

0.265

Postura de Venta

0.2739

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.138 Rango de 52 semanas 10.80

Capitalización de Mercado [m]

5.369M

Precio Anterior

0.29

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

7,174,184

Acciones en circulación

18,512,084

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.31

Beneficio por acción (BPA)

-0.94

turnover

Beneficio neto

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.aptevotherapeutics.com

Sede

Wilmington, Delaware, USA

Fundado

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was US$0.29. Over the last year, Aptevo Therapeutics shares have traded in a share price range of US$ 0.138 to US$ 10.80.

Aptevo Therapeutics currently has 18,512,084 shares in issue. The market capitalisation of Aptevo Therapeutics is US$5.37 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.31.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.0486	20.1325600663	0.2414	0.3255	0.2022	3296011	0.27674153	CS
4	0.0156	5.68513119534	0.2744	0.3533	0.2022	3179046	0.28169439	CS
12	-0.0616	-17.5199089875	0.3516	0.515	0.138	7174184	0.2841753	CS
26	-0.474	-62.0418848168	0.764	0.89	0.138	6171618	0.41128975	CS
52	-8.818	-96.8159859464	9.108	10.8	0.138	3468401	0.7171699	CS
156	-325.75	-99.9110538584	326.04	971.5156	0.138	1616108	134.64061609	CS
260	-27.7908	-98.9672658899	28.0808	2640	0.138	1153153	205.39417295	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
AALAmerican Airlines Group Inc	US$ 14.46 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 67.36 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.22 (0.00%)	0
AACGATA Creativity Global	US$ 1.02 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 14.46 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 67.36 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.22 (0.00%)	0
AACGATA Creativity Global	US$ 1.02 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 14.46 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 67.36 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.22 (0.00%)	0
AACGATA Creativity Global	US$ 1.02 (0.00%)	0